We observed similar effects upon treatment with a MEK inhibitor (Fig. 2b) and in three other BRAF-mutant melanoma cell lines with BRAF or MEK inhibitors (Supplementary Fig. 2a). This evidence concerns the gene MAP2K7 and melanoma.